OnKure
OKUR
OnKure (OKUR) news
Recent news
Onkure Therapeutics Inc.: Oppenheimer cuts target price to $14 from $30
AInvest Wire · Aug 14, 2026Onkure Therapeutics registering offer and sale of Class A common stock up to $100 mln through Leerink Partners - SEC filing
Onkure Therapeutics Inc. has filed with the U.S. Securities and Exchange Commission (SEC) to register the offer and sale of up to $100 million in shares of its Class A common stock, according to a recent SEC filing. The company is working with Leerink Partners as the underwriter for the offering.…
AInvest Wire · Aug 4, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.